1 |
Bandala C, Perez-Santos JL, Lara-Padilla E, et al (2013). Effect of botulinum toxin a on proliferation and apoptosis in the t47d breast cancer cell line. Asian Pac J Cancer Prev, 14, 891-4.
DOI
|
2 |
Bermudes D, Zheng LM ,King IC (2002). Live bacteria as anticancer agents and tumor-selective protein delivery vectors. Curr Opin Drug Discov Devel, 5, 194-9.
|
3 |
Bezine E, Vignard J ,Mirey G (2014). The cytolethal distending toxin effects on mammalian cells: A DNA damage perspective. Cells, 3, 592-615.
DOI
|
4 |
Engedal N, Skotland T, Torgersen ML, et al (2011). Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol, 4, 32-46.
DOI
|
5 |
Frankel AE, Rossi P, Kuzel TM, et al (2002). Diphtheria fusion protein therapy of chemoresistant malignancies. Curr Cancer Drug Targets, 2, 19-36.
DOI
|
6 |
Govindan R, Page N, Morgensztern D, et al (2006). Changing epidemiology of small-cell lung cancer in the united states over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol, 24, 4539-44.
DOI
|
7 |
Hough CD, Sherman-Baust CA, Pizer ES, et al (2000). Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res, 60, 6281-7.
|
8 |
Kominsky SL, Vali M, Korz D, et al (2004). Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol, 164, 1627-33.
DOI
|
9 |
Lai CK, Lu YL, Hsieh JT, et al (2014). Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy. Nanomedicine (Lond), 9, 803-17.
DOI
|
10 |
Liu CC, Yang H, Zhang LL, et al (2014). Biotoxins for cancer therapy. Asian Pac J Cancer Prev, 15, 4753-8.
DOI
|
11 |
Michl P, Buchholz M, Rolke M, et al (2001). Claudin-4: A new target for pancreatic cancer treatment using clostridium perfringens enterotoxin. Gastroenterology, 121, 678-84.
DOI
|
12 |
Mizrahi A, Hochberg A, Amiur S, et al (2010). Targeting diphtheria toxin and tnf alpha expression in ovarian tumors using the h19 regulatory sequences. Int J Clin Exp Med, 3, 270-82.
|
13 |
Nishihara T ,Koseki T (2004). Microbial etiology of periodontitis. Periodontol 2000, 36, 14-26.
DOI
|
14 |
Pastan I (1997). Targeted therapy of cancer with recombinant immunotoxins. Biochim Biophys Acta, 1333, 1-6.
|
15 |
Patyar S, Joshi R, Byrav DS, et al (2010). Bacteria in cancer therapy: A novel experimental strategy. J Biomed Sci, 17, 21.
DOI
|
16 |
Qiu Y, Peng GL, Liu QC, et al (2012). Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pcea-tk/cd). Cancer Lett, 316, 31-8.
DOI
|
17 |
Saiki K, Konishi K, Gomi T, et al (2001). Reconstitution and purification of cytolethal distending toxin of actinobacillus actinomycetemcomitans. Microbiol Immunol, 45, 497-506.
DOI
|
18 |
Sargent JM ,Taylor CG (1989). Appraisal of the mtt assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer, 60, 206-10.
DOI
|
19 |
Sun S, Schiller JH, Spinola M, et al (2007). New molecularly targeted therapies for lung cancer. J Clin Invest, 117, 2740-50.
DOI
|
20 |
Wang S, Shu JZ, Cai Y, et al (2012). Establishment and characterization of mtdh knockdown by artificial microrna interference - functions as a potential tumor suppressor in breast cancer. Asian Pac J Cancer Prev, 13, 2813-8.
DOI
|
21 |
Wising C, Magnusson M, Ahlman K, et al (2010). Toxic activity of the cdtb component of haemophilus ducreyi cytolethal distending toxin expressed from an adenovirus 5 vector. Apmis, 118, 143-9.
DOI
|
22 |
Yamamoto K, Tominaga K, Sukedai M, et al (2004). Delivery of cytolethal distending toxin b induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro. Eur J Oral Sci, 112, 445-51.
DOI
|
23 |
Yildirim F, Baha A, Yurdakul AS, et al (2015). Comparison of single agent gemcitabine and docetaxel in second-line therapy for advanced stage non-small cell lung cancer in a university hospital in turkey. Asian Pac J Cancer Prev, 16, 7859-65.
DOI
|
24 |
Zhou W, Wang J, Man WY, et al (2015). Sirna silencing ezh2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells. Asian Pac J Cancer Prev, 16, 2425-30.
DOI
|